Trials / Completed
CompletedNCT00080054
A Study of Motexafin Gadolinium and Temozolomide for the Treatment of Malignant Gliomas
Phase I Trial of Motexafin Gadolinium (MGd) in Combination With Temozolomide for Treatment of Malignant Gliomas
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (planned)
- Sponsor
- Pharmacyclics LLC. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to find out about the safety of adding the investigational drug motexafin gadolinium to a standard course of chemotherapy with temozolomide for patients with malignant glioma. Secondly, the study will determine how many patients will respond to this treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Motexafin Gadolinium Injection |
Timeline
- First posted
- 2004-03-23
- Last updated
- 2009-04-03
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00080054. Inclusion in this directory is not an endorsement.